文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

尿中性粒细胞明胶酶相关脂质运载蛋白与血浆IL-6在严重急性肾损伤停止连续静脉-静脉血液透析滤过中的应用:多中心前瞻性观察研究

Urinary neutrophil gelatinase-associated lipocalin and plasma IL-6 in discontinuation of continuous venovenous hemodiafiltration for severe acute kidney injury: a multicenter prospective observational study.
PubMed 文献 · Ann Intensive Care · 2023-05-15
一句话结论在严重AKI接受CVVHDF的成人中,停用CVVHDF时尿NGAL较低与7天内脱离RRT或存活相关(93.8 vs 999 ng/ml,p<0.01)。

这项多中心前瞻性观察研究在7个大学附属ICU纳入133例需要CVVHDF的严重AKI成人,检测CVVHDF启动时、启动后24h、48h及停用时的尿NGAL和血浆IL-6。28例未停用CVVHDF即死亡,其启动时尿NGAL和血浆IL-6显著高于存活者。105例存活者中,停用后7天内70例未再需RRT或死亡(成功组),35例死亡或再需RRT(失败组);成功组停用时尿NGAL显著更低(93.8 vs 999 ng/ml,p<0.01),两组血浆IL-6无显著差异。CVVHDF启动后48h内尿NGAL升高见于CVVHDF未存活者和停用失败者。

要点

  • CVVHDF启动时尿NGAL和血浆IL-6在CVVHDF未存活者中显著高于存活者。
  • 停用CVVHDF时尿NGAL成功组93.8 ng/ml vs 失败组999 ng/ml(p<0.01)。
  • 停用时血浆IL-6在成功组与失败组间无显著差异。
  • CVVHDF启动后48h内尿NGAL升高见于CVVHDF未存活者和停用失败者。
  • 尿NGAL在CVVHDF启动时与死亡相关、停用时与RRT依赖相关,系列变化可能帮助预测预后。

适用人群与场景

  • 在7个大学附属ICU中,需要CVVHDF的严重AKI成人患者。

研究设计与关键结果

  • 研究类型:多中心前瞻性观察研究;样本量:133例成人严重AKI患者;7个大学附属ICU。
  • 28例未停用CVVHDF即死亡(CVVHDF未存活者);CVVHDF启动时尿NGAL和血浆IL-6在CVVHDF未存活者中显著高于存活者。
  • 105例CVVHDF存活者中,停用后7天内70例未再需RRT或死亡(成功组),35例死亡或再需RRT(失败组)。
  • 停用CVVHDF时尿NGAL成功组93.8 ng/ml vs 失败组999 ng/ml(p<0.01);停用时血浆IL-6两组无显著差异。
  • CVVHDF启动后48h内尿NGAL升高见于CVVHDF未存活者和停用失败者。

证据类型、等级与局限

  • 证据类型:多中心前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,CVVHDF启动时和停用时尿NGAL分别与死亡和RRT依赖相关,尿NGAL系列变化可能帮助预测接受CVVHDF的AKI患者预后。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Patients with severe acute kidney injury (AKI) who require continuous venovenous hemodiafiltration (CVVHDF) in intensive care unit (ICU) are at high mortality risk. Little is known about clinical biomarkers for risk prediction, optimal initiation, and optimal discontinuation of CVVHDF.

METHODS: This prospective observational study was conducted in seven university-affiliated ICUs. For urinary neutrophil gelatinase-associated lipocalin (NGAL) and plasma IL-6 measurements, samples were collected at initiation, 24 h, 48 h after, and CVVHDF discontinuation in adult patients with severe AKI. The outcomes were deaths during CVVHDF and CVVHDF dependence.

RESULTS: A total number of 133 patients were included. Twenty-eight patients died without CVVHDF discontinuation (CVVHDF nonsurvivors). Urinary NGAL and plasma IL-6 at the CVVHDF initiation were significantly higher in CVVHDF nonsurvivors than in survivors. Among 105 CVVHDF survivors, 70 patients were free from renal replacement therapy (RRT) or death in the next 7 days after discontinuation (success group), whereas 35 patients died or needed RRT again (failure group). Urinary NGAL at CVVHDF discontinuation was significantly lower in the success group (93.8 ng/ml vs. 999 ng/ml, p < 0.01), whereas no significant difference was observed in plasma IL-6 between the groups. Temporal elevations of urinary NGAL levels during the first 48 h since CVVHDF initiation were observed in CVVHDF nonsurvivors and those who failed in CVVHDF discontinuation.

CONCLUSIONS: Urinary NGAL at CVVHDF initiation and discontinuation was associated with mortality and RRT dependence, respectively. The serial changes of urinary NGAL might also help predict the prognosis of patients with AKI on CVVHDF.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Komaru Y, Oguchi M, Sadahiro T, et al. Urinary neutrophil gelatinase-associated lipocalin and plasma IL-6 in discontinuation of continuous venovenous hemodiafiltration for severe acute kidney injury: a multicenter prospective observational study. Ann Intensive Care. 2023. PMID: 37184598. doi:10.1186/s13613-023-01137-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。